In this section EBTC brings you a selection of news, insights and announcements from the cleantech sectors, activities in the EU and India, partners, general trade, business and research news, and more.
- Category: IPR News
- Created on Friday, 07 April 2017 11:32
The focused seminar on “Protecting pharmaceutical and biotechnology inventions in Europe”, specifically organised for experts and practitioners in this field, was co-organised by the European Business and Technology Centre (EBTC), the European Patent Office (EPO), the Association of Biotechnology-Led Enterprises (ABLE) and the Council of EU Chambers of Commerce in India (CEUCCI) in Mumbai on 30 March 2017. The event was specifically designed for IP practitioners and industry experts based in Mumbai. It put a special focus on the EPO’s practice in the field of pharmaceuticals and biotechnology, and on practical issues related to filing and prosecution at EPO.
In his welcome address, Mr. Poul V. Jensen, EBTC Director, provided insights on how EBTC is promoting and indigenising European technologies as well as innovations to suit the local needs in India through various projects, programmes and initiatives, enabling Indo-European collaborations. Dr A. Stamatopoulos, Principal Director Biotechnology at EPO, presented a brief overview of the latest developments at the European Patent Office. ABLE’s Chief Operating Officer, Mr. Narayanan Suresh, shed light on the activities pursued by his association and how ABLE is addressing challenges and issues faced by companies in the pharmaceuticals and biotechnology sector. ABLE is a not-for-profit pan-India organisation that represents the Indian biotechnology sector. It has over 400 members from across India representing all verticals of the sector like agribiotech, bio-pharma, industrial biotech and bioinformatics. The Director of the Council of EU Chambers of Commerce in India (CEUCCI), Dr Renu Shome, deliberated on European initiatives to foster Indo-European collaboration. She highlighted that CEUCCI is an important link between European Union-Indian Businesses. CEUCCI organises events and business seminars so that businesses from both regions can interact regularly.
The technical sessions were moderated by Mr Nicholas Körnig, International Co-operation Administrator from EPO. The seminar addressed the following topics: European Patent Office and the European patent system; the procedures at the EPO from filing to appeal; what is and what is not patentable in the fields of pharmaceuticals and biotechnology with practical examples; procedural and patentability aspects of the grant and opposition procedure at the EPO; and practical experiences in protecting pharma and biotech inventions from India in Europe. The speakers were: Dr. Dieter Tzschoppe, Director Pharmaceuticals, Mr. Klaus-Peter Döpfer, Director Biotechnology and Mr. Durgesh Mukharya, Partner, K&S Partners.
The presentations were followed by a very interactive consultation with the EPO experts. In general, the participants expressed a need for more regular updates about the latest developments in the European patent system and their appreciation of the EPO’s efforts to address timeliness and costs through the “Early Certainty” initiative and the implementation of the upcoming Unitary patent system.
The event was attended by more than 50 senior representatives from law firms, industry experts, as well as IP and trade counsellors from EU Embassies.
The seminar’s content and the EPO efforts have been very much appreciated by the participants and the law firms they represent. They expressed the wish to organise further seminars of this kind with a clear focus on specific domains in the future.
The seminar was organized within the framework of the EPO/EBTC co-operation programme to foster IPR co-operation between Europe and India.
EPO Practices and Procedures in the Field of Pharmaceuticals and Biotechnology - EPO seminar for Patent Attorneys, New Delhi
- Category: IPR News
- Created on Tuesday, 28 March 2017 12:24
The European Business and Technology Centre (EBTC) and the European Patent Office (EPO) co-organised a focused seminar on “EPO Practices and Procedures in the Field of Pharmaceuticals and Biotechnology”, in New Delhi on 27th March 2017. The event was specifically designed for IP practitioners and industry experts based in Delhi and the National Capital Region (NCR). It put a special focus on the European practices in the pharmaceutical and biotechnology domain.
The presentations were followed by a very interactive discussion. The participants expressed in particular the need to increase awareness about the EPO Guidelines for Examination as well as the instructions on the practices and procedures which are followed in the various aspects of the examination.
After a welcome address by Mr. Poul Jensen, EBTC Director, the leading EPO experts on the subject matter, Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr. Dieter Tzschoppe, Director Pharmaceuticals, and Mr. Klaus-Peter Döpfer, Director Biotechnology, gave three very insightful presentations on latest developments at the EPO, patentable and non-patentable subject matter in the fields of pharmaceuticals and biotechnology including procedural and patentability aspects of the grant and opposition procedure at the EPO for applications and patents relating to pharmaceuticals and biotechnology.
The event was attended by 32 senior representatives from law firms and IP counsellors.
Group photo of the seminars attendees
The seminar’s content and the efforts by the EPO have been very much appreciated by the participants and the law firms they represent. They expressed the wish to organise further seminars of this kind with a clear focus on specific domains in the future.
The seminar was organized within the frame of the EPO/EBTC activities in Indo-European cooperation for intellectual property rights (IPR), as EBTC is the official implementation partner of the European Patent Office (EPO) in India.
- Category: Political News
- Created on Tuesday, 21 March 2017 13:21
A landslide win in Uttar Pradesh could give the national government of India, under Prime Minister Narendra Modi, fresh energy to implement the initiatives it launched in the past three years for industry, technology and the 21st century economy.
The legislative elections in Uttar Pradesh, whose results were made public on 11th March 2017, showed sweeping support for the Bhartiya Janata Party (BJP) and the Modi government. Uttar Pradesh, the most populous state in India, accounts for 16% of the country’s population, with over 200 million inhabitants. The BJP won with a phenomenal majority of more than 77% of the seats in the state assemblies, up from only 11.6% at the last elections in 2012. Counting its allies, that gives the party a governing majority of more than 80%.
These results will contribute to the stability of the Indian political landscape, with Prime Minister Narendra Modi and his party stronger than ever and in position to push through key reform measures and initiatives. The election outcome, which came in the backdrop of demonetization, was proof that Modi had not lost the support of his base. The expected stability should also trigger a new wave of investments by the domestic industry, fueling growth in the next years.
The prime minister, in his address at 104th Indian Science Congress in January 2017, had reaffirmed his objective to have India among the top three countries in the world in science and technology by 2030. This goes hand in glove with his major projects since coming to power in 2014. Indeed, Modi has launched many important initiatives in domains India has identified as key to its future, among those energy, environment, industry, technology, and digital economy.
- Swachh Bharat Abhiyan, or the Clean India Movement was launched in October 2014 as a campaign to clean the streets and infrastructures of India. It is India's largest ever initiative in this area. Its objective is to reduce or eliminate open defecation through construction of individual, cluster and community toilets, and to be able to monitor latrine use.
- Clean Ganges: Narendra Modi has given strong support to the rejuvenation of the Ganges river, putting the National Ganga Council under his direct chairmanship and pushing forward initiatives to improve the quality and environment of what is today one of the heaviest polluted rivers in the world.
- Smart Cities: India’s Smart Cities Mission, which was launched in 2015, aims to foster sustainable and citizen-friendly urban development in the country, through a spearhead of more than 100 cities, ports, Greenfield projects and private smart cities.
Other national strategies which will benefit from a strong Modi government include his flagship initiative, Make in India, which was launched by Prime Minister in 2014 with the goal to transform India into a global design and manufacturing hub; Skill India, which aims to improve technical training on a large scale to provide the cutting-edge industries fostered by Make in India with the manpower they need; and Digital India, whose official objective is to “transform India into a digitally empowered society and knowledge economy” through digital infrastructures, e-services and citizens’ education.
These initiatives offer many opportunities for Europe-India technology collaborations, sparking interest across borders, and the boost to Modi’s government will provide European companies an enabling environment in which to invest, find partners, and provide solutions to implement India’s strategies. EBTC has been developing its activities in those same areas for a number of years. Taking advantage of the auspicious climate, we are launching several new projects and initiatives over the next months.